{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:27:44Z","timestamp":1789612064361,"version":"build-2803163510"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002742","name":"Banaras Hindu University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002742","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ijbiomac.2023.128780","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T21:51:25Z","timestamp":1702677085000},"page":"128780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"P1","title":["A comprehensive review on structural and therapeutical insight of Cerebroside sulfotransferase (CST) - An important target for development of substrate reduction therapy against metachromatic leukodystrophy"],"prefix":"10.1016","volume":"258","author":[{"given":"Nivedita","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2023.128780_bb0005","article-title":"Metachromatic leukodystrophy: diagnosis, modeling, and treatment approaches","volume":"7","author":"Shaimardanova","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128780_bb0010","article-title":"Myelin lipid metabolism and its role in myelination and myelin maintenance","volume":"4","author":"Barnes-V\u00e9lez","year":"2022","journal-title":"Innovation (Camb)"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128780_bb0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00401-017-1739-1","article-title":"Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms","volume":"134","author":"van der Knaap","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128780_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-009-0601-5","article-title":"Oligodendrocytes: biology and pathology","volume":"119","author":"Bradl","year":"2010","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128780_bb0025","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1152\/physrev.00031.2018","article-title":"Myelin in the central nervous system: structure, function, and pathology","volume":"99","author":"Stadelmann","year":"2019","journal-title":"Physiol. Rev."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.128780_bb0030","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1172\/JCI90610","article-title":"Oligodendroglia: metabolic supporters of neurons","volume":"127","author":"Philips","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128780_bb0035","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020479","article-title":"Oligodendrocytes: myelination and axonal support","volume":"8","author":"Simons","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.128780_bb0040","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1021\/acsmedchemlett.0c00120","article-title":"Brain penetrable inhibitors of ceramide galactosyltransferase for the treatment of lysosomal storage disorders","volume":"11","author":"Thurairatnam","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.128780_bb0045","doi-asserted-by":"crossref","first-page":"13104","DOI":"10.1038\/srep13104","article-title":"Enzyme replacement in the CSF to treat metachromatic leukodystrophy in mouse model using single intracerebroventricular injection of self-complementary AAV1 vector","author":"Hironaka","year":"2015","journal-title":"Sci. Rep."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.128780_bb0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymgme.2020.07.002","article-title":"Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: results from a phase 1\/2 clinical trial","volume":"131","author":"\u00cd Dali","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"10322","key":"10.1016\/j.ijbiomac.2023.128780_bb0055","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0140-6736(22)00057-5","article-title":"Gene therapy offers new hope for children with metachromatic leukodystrophy","volume":"399","author":"Kurtzberg","year":"2022","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.128780_bb0060","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/jnr.23792","article-title":"Gene therapy for metachromatic leukodystrophy","volume":"94","author":"Rosenberg","year":"2016","journal-title":"J. Neurosci. Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.128780_bb0065","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2016.2067","article-title":"Long-term outcome of allogeneic hematopoietic stem cell transplantation in patients with juvenile metachromatic leukodystrophy compared with nontransplanted control patients","volume":"73","author":"Groeschel","year":"2016","journal-title":"JAMA Neurol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.128780_bb0070","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1016\/j.bbmt.2019.09.003","article-title":"Hematopoietic stem cell transplantation to treat leukodystrophies: clinical practice guidelines from the Hunter\u2019s Hope Leukodystrophy Care Network","volume":"25","author":"Page","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128780_bb0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/acn3.50975","article-title":"Metachromatic leukodystrophy and transplantation: remyelination, no cross-correction","volume":"7","author":"Wolf","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0080","doi-asserted-by":"crossref","first-page":"14486","DOI":"10.1038\/s41598-021-93601-1","article-title":"Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor","volume":"11","author":"Babcock","year":"2021","journal-title":"Sci. Rep."},{"issue":"457","key":"10.1016\/j.ijbiomac.2023.128780_bb0085","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1651-2227.2008.00656.x","article-title":"Substrate reduction therapy","volume":"97","author":"Platt","year":"2008","journal-title":"Acta Paediatr."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128780_bb0090","article-title":"Enzyme replacement and substrate reduction therapy for Gaucher disease","author":"Shemesh","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.128780_bb0095","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/acn3.193","article-title":"Sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy","volume":"2","author":"Dali","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.128780_bb0100","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.3390\/ijms20112783","article-title":"A structure-based drug discovery paradigm","volume":"20","author":"Batool","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.128780_bb0105","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2174\/1568026618666180813152921","article-title":"Structure-based drug design strategies and challenges","volume":"18","author":"Wang","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.128780_bb0110","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.drudis.2022.03.006","article-title":"Structure-based drug repurposing: traditional and advanced AI\/ML-aided methods","volume":"27","author":"Choudhury","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2021.100042","article-title":"Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2","volume":"2","author":"Prasad","year":"2021","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0120","first-page":"1","article-title":"Comprehensive molecular docking and dynamic simulations for drug repurposing of clinical drugs against multiple cancer kinase targets","author":"Shaikh","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"57","key":"10.1016\/j.ijbiomac.2023.128780_bb0125","doi-asserted-by":"crossref","first-page":"36181","DOI":"10.1039\/D1RA05320E","article-title":"Computational methods directed towards drug repurposing for COVID-19: advantages and limitations","volume":"11","author":"Sharma","year":"2021","journal-title":"RSC Adv."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.128780_bb0130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2183\/pjab.89.129","article-title":"Biosynthesis and biological function of sulfoglycolipids","volume":"89","author":"Honke","year":"2013","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128780_bb0135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/jnc.13738","article-title":"Novel molecular insights into the critical role of sulfatide in myelin maintenance\/function","volume":"139","author":"Palavicini","year":"2016","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.128780_bb0140","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1194\/jlr.R026682","article-title":"Role of sulfatide in normal and pathological cells and tissues","volume":"53","author":"Takahashi","year":"2012","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128780_bb0150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/toxsci\/kfj061","article-title":"Human sulfotransferases and their role in chemical metabolism","volume":"90","author":"Gamage","year":"2006","journal-title":"Toxicol. Sci."},{"issue":"27","key":"10.1016\/j.ijbiomac.2023.128780_bb0155","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1002\/anie.200300631","article-title":"Sulfotransferases: structure, mechanism, biological activity, inhibition, and synthetic utility","volume":"43","author":"Chapman","year":"2004","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.128780_bb0160","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00216-012-5944-4","article-title":"Recent advances in sulfotransferase enzyme activity assays","volume":"403","author":"Paul","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.128780_bb0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/03602532.2013.835613","article-title":"Interactions of cytosolic sulfotransferases with xenobiotics","volume":"45","author":"James","year":"2013","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0170","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12985-016-0491-9","article-title":"Cytosolic sulfotransferase 1A1 regulates HIV-1 minus-strand DNA elongation in primary human monocyte-derived macrophages","volume":"13","author":"Swann","year":"2016","journal-title":"Virol. J."},{"issue":"55","key":"10.1016\/j.ijbiomac.2023.128780_bb0175","doi-asserted-by":"crossref","first-page":"32165","DOI":"10.1039\/C9RA07567D","article-title":"Structure-based design of nucleoside-derived analogues as sulfotransferase inhibitors","volume":"9","author":"Kershaw","year":"2019","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128780_bb0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/09168451.2016.1222266","article-title":"Updated perspectives on the cytosolic sulfotransferases (SULTs) and SULT-mediated sulfation","volume":"81","author":"Suiko","year":"2017","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.128780_bb0185","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/sj.onc.1209376","article-title":"Pharmacogenetics of human cytosolic sulfotransferases","volume":"25","author":"Nowell","year":"2006","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.128780_bb0190","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1021\/acs.jcim.3c00275","article-title":"Predicting regioselectivity of cytosolic sulfotransferase metabolism for drugs","volume":"63","author":"\u00d6eren","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.128780_bb0195","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1369\/0022155412461256","article-title":"Proteoglycan synthesis and Golgi organization in polarized epithelial cells","volume":"60","author":"Dick","year":"2012","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0200","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fonc.2019.00507","article-title":"The emerging roles of heparan sulfate 3-O-sulfotransferases in cancer","volume":"9","author":"Denys","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0205","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3389\/fimmu.2020.00570","article-title":"HS and inflammation: a potential playground for the Sulfs?","volume":"11","author":"El Masri","year":"2020","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.128780_bb0210","first-page":"16960","article-title":"Estrogen sulfotransferase induction inhibits breast cancer cell line MCF-7 proliferation","volume":"22","author":"Jiang","year":"2019","journal-title":"Biomed. J. Sci. Tech. Res."},{"issue":"29","key":"10.1016\/j.ijbiomac.2023.128780_bb0215","doi-asserted-by":"crossref","first-page":"11824","DOI":"10.1073\/pnas.1205377109","article-title":"Sulfonation of glycopeptide antibiotics by sulfotransferase StaL depends on conformational flexibility of aglycone scaffold","volume":"109","author":"Shi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.128780_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158967","article-title":"Pivotal role of carbohydrate sulfotransferase 15 in fibrosis and mucosal healing in mouse colitis","volume":"11","author":"Suzuki","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0225","series-title":"Handbook of Glycosyltransferases and Related Genes","article-title":"Galactose-3-O-Sulfotransferase 1-4 (GAL3ST1-4)","author":"Honke","year":"2014"},{"issue":"48","key":"10.1016\/j.ijbiomac.2023.128780_bb0230","doi-asserted-by":"crossref","first-page":"16715","DOI":"10.1073\/pnas.0403681101","article-title":"A small-molecule switch for Golgi sulfotransferases","volume":"101","author":"de Graffenried","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"17","key":"10.1016\/j.ijbiomac.2023.128780_bb0235","first-page":"3800","article-title":"Cancer-associated expression of glycolipid sulfotransferase gene in human renal cell carcinoma cells","volume":"58","author":"Honke","year":"1998","journal-title":"Cancer Res."},{"issue":"29","key":"10.1016\/j.ijbiomac.2023.128780_bb0240","doi-asserted-by":"crossref","first-page":"26988","DOI":"10.1074\/jbc.M100348200","article-title":"A novel human Gal-3-O-sulfotransferase: molecular cloning, characterization, and its implications in biosynthesis of (SO(4)-3)Galbeta1-4(Fucalpha1-3)GlcNAc","volume":"276","author":"El-Fasakhany","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128780_bb0245","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1080\/14756366.2020.1791841","article-title":"Synthesis and structure-activity relationships of cerebroside analogues as substrates of cerebroside sulphotransferase and discovery of a competitive inhibitor","volume":"35","author":"Li","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0250","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0021-9258(18)45995-9","article-title":"Purification of the testicular galactolipid: 3'-phosphoadenosine 5'-phosphosulfate sulfotransferase","volume":"267","author":"Sakac","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0255","doi-asserted-by":"crossref","first-page":"24041","DOI":"10.1016\/S0021-9258(18)35942-8","article-title":"Purification and activation of brain sulfotransferase","volume":"267","author":"Sundaram","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.128780_bb0260","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1046\/j.1432-1327.2000.01139.x","article-title":"cDNA cloning, genomic cloning, and tissue-specific regulation of mouse cerebroside sulfotransferase","volume":"267","author":"Hirahara","year":"2000","journal-title":"Eur. J. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.128780_bb0265","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/B:GLYC.0000043749.06556.3d","article-title":"Biological roles of sulfoglycolipids and pathophysiology of their deficiency","volume":"21","author":"Honke","year":"2004","journal-title":"Glycoconj. J."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.128780_bb0270","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.97.4.1107","article-title":"Topography of cerebroside sulfotransferase in Golgi-enriched vesicles from rat brain","volume":"97","author":"Tennekoon","year":"1983","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.128780_bb0275","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.4049\/jimmunol.179.10.6770","article-title":"Sulfated glycosphingolipid as mediator of phagocytosis: SM4s enhances apoptotic cell clearance and modulates macrophage activity","volume":"179","author":"Popovic","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128780_bb0280","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2119\/molmed.2015.00088","article-title":"Efficacy of enzyme and substrate reduction therapy with a novel antagonist of glucosylceramide synthase for Fabry disease","volume":"21","author":"Ashe","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2021.103670","article-title":"Sulfatide in health and disease. The evaluation of sulfatide in cerebrospinal fluid as a possible biomarker for neurodegeneration","volume":"116","author":"Blomqvist","year":"2021","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0290","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1476-511X-10-28","article-title":"Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice","volume":"10","author":"Blomqvist","year":"2011","journal-title":"Lipids Health Dis."},{"issue":"15","key":"10.1016\/j.ijbiomac.2023.128780_bb0295","article-title":"Cerebral white matter myelination and relations to age, gender, and cognition: a selective review","author":"Buyanova","year":"2021","journal-title":"Front. Hum. Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128780_bb0300","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s41687-018-0041-x","article-title":"Development of the impact of juvenile metachromatic leukodystrophy on physical activities scale","volume":"2","author":"Brown","year":"2017","journal-title":"J. Patient Rep. Outcomes"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128780_bb0305","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/abio.1999.4264","article-title":"A continuous assay for the spectrophotometric analysis of sulfotransferases using aryl sulfotransferase IV","volume":"274","author":"Burkart","year":"1999","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0310","doi-asserted-by":"crossref","first-page":"13654","DOI":"10.1038\/srep13654","article-title":"EXTL2 and EXTL3 inhibition with siRNAs as a promising substrate reduction therapy for Sanfilippo C syndrome","volume":"5","author":"Canals","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0315","doi-asserted-by":"crossref","first-page":"1080161","DOI":"10.3389\/fmolb.2022.1080161","article-title":"The repertoire of protein-sulfatide interactions reveal distinct modes of sulfatide recognition","volume":"9","author":"Capelluto","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128780_bb0320","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(00)80093-8","article-title":"Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability","volume":"86","author":"Coetzee","year":"1996","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.128780_bb0325","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/diseases4040033","article-title":"Genetic substrate reduction therapy: a promising approach for lysosomal storage disorders","volume":"4","author":"Coutinho","year":"2016","journal-title":"Diseases"},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.128780_bb0330","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3390\/ijms17071065","article-title":"Less is more: substrate reduction therapy for lysosomal storage disorders","volume":"17","author":"Coutinho","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0335","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2147\/TCRM.S119967","article-title":"Four novel ARSA gene mutations with pathogenic impacts on metachromatic leukodystrophy: a bioinformatics approach to predict pathogenic mutations","volume":"13","author":"Dehghan Manshadi","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128780_bb0340","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bcmd.2006.07.002","article-title":"RNAi-mediated inhibition of the glucosylceramide synthase (GCS) gene: a preliminary study towards a therapeutic strategy for Gaucher disease and other glycosphingolipid storage diseases","volume":"37","author":"Diaz-Font","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.128780_bb0345","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3390\/pharmaceutics13101615","article-title":"Safety evaluation of nanotechnology products","volume":"13","author":"Domb","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128780_bb0350","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ejhg.2009.144","article-title":"Impairment of glycosaminoglycan synthesis in mucopolysaccharidosis type IIIA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease","volume":"18","author":"Dziedzic","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0355","series-title":"GeneReviews\u00ae [Internet]","article-title":"Deficiency","author":"Gomez-Ospina","year":"2006"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128780_bb0360","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1160\/TH07-05-0351","article-title":"Effect of an anti-sulfatide single-chain antibody probe on platelet function","volume":"99","author":"Guchhait","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.128780_bb0365","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1471-4159.2002.00997.x","article-title":"Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer\u2019s disease: potential role in disease pathogenesis","volume":"82","author":"Han","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0370","series-title":"Glycoscience Protocols (GlycoPODv2) [Internet]","article-title":"Enzyme assay of cerebroside sulfotransferase","volume":"2021","author":"Honke","year":"2021"},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0375","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1002\/pat.4713","article-title":"Biodegradable polymers in gene-silencing technology","volume":"30","author":"Hosseinkhani","year":"2019","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0380","series-title":"Nanomaterials in Advanced Medicine","isbn-type":"print","doi-asserted-by":"crossref","DOI":"10.1002\/9783527818921","author":"Hosseinkhani","year":"2019","ISBN":"https:\/\/id.crossref.org\/isbn\/9783527345496"},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0385","series-title":"Biomedical Engineering: Materials, Technology, and Applications","isbn-type":"print","doi-asserted-by":"crossref","DOI":"10.1002\/9783527826674","author":"Hosseinkhani","year":"2022","ISBN":"https:\/\/id.crossref.org\/isbn\/9783527347469"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128780_bb0390","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/pharmaceutics15030856","article-title":"Gene therapy for regenerative medicine","volume":"15","author":"Hosseinkhani","year":"2023","journal-title":"Pharmaceutics"},{"issue":"15","key":"10.1016\/j.ijbiomac.2023.128780_bb0395","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1523\/JNEUROSCI.22-15-06507.2002","article-title":"A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on myelinated axon but not essential for initial cluster formation","volume":"22","author":"Ishibashi","year":"2002","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.128780_bb0400","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0163-7827(97)00011-8","article-title":"Chemistry and functional distribution of sulfoglycolipids","volume":"36","author":"Ishizuka","year":"1997","journal-title":"Prog. Lipid Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.128780_bb0405","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF03195237","article-title":"Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases","volume":"48","author":"Jak\u00f3bkiewicz-Banecka","year":"2007","journal-title":"J. Appl. Genet."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.128780_bb0410","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.2174\/138920111798376932","article-title":"Substrate reduction therapies for mucopolysaccharidoses","volume":"12","author":"Jak\u00f3bkiewicz-Banecka","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.128780_bb0415","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.4049\/jimmunol.181.11.8077","article-title":"Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells","volume":"181","author":"Jeon","year":"2008","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128780_bb0420","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ejhg.2009.143","article-title":"Gene silencing of EXTL2 and EXTL3 as a substrate deprivation therapy for heparan sulphate storing mucopolysaccharidoses","volume":"18","author":"Kaidonis","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128780_bb0425","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41531-023-00558-1","article-title":"Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP Parkinson\u2019s disease primate model","volume":"9","author":"Kaya","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.128780_bb0430","first-page":"2484","article-title":"Involvement of protein kinase C in the regulation of glycolipid sulfotransferase activity levels in renal cell carcinoma cells","volume":"53","author":"Kobayashi","year":"1993","journal-title":"Cancer Res."},{"issue":"34","key":"10.1016\/j.ijbiomac.2023.128780_bb0435","doi-asserted-by":"crossref","first-page":"55811","DOI":"10.18632\/oncotarget.10046","article-title":"Sulfonation, an underexploited area: from skeletal development to infectious diseases and cancer","volume":"7","author":"Leung","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0440","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.chroma.2015.06.053","article-title":"A capillary electrophoresis method with dynamic pH junction stacking for the monitoring of cerebroside sulfotransferase","volume":"1407","author":"Li","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0445","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/bmj.p370","article-title":"Toddler becomes first child to receive gene therapy for fatal disorder on the NHS","volume":"380","author":"Mahase","year":"2023","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.128780_bb0450","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/glia.20292","article-title":"Sulfatide is essential for the maintenance of CNS myelin and axon structure","volume":"53","author":"Marcus","year":"2006","journal-title":"Glia"},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.128780_bb0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015033","article-title":"Substrate reduction augments the efficacy of enzyme therapy in a mouse model of Fabry disease","volume":"5","author":"Marshall","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.128780_bb0460","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1194\/jlr.M051839","article-title":"Renal sulfatides: sphingoid base-dependent localization and region-specific compensation of CerS2-dysfunction","volume":"55","author":"Marsching","year":"2014","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128780_bb0465","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1021\/acschembio.1c00978","article-title":"Fluorinated phosphoadenosine 5\u2032-phosphosulfate analogues for continuous sulfotransferase activity monitoring and inhibitor screening by 19F NMR spectroscopy","volume":"17","author":"Mlynarska-Cieslak","year":"2022","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128780_bb0470","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1038\/s41598-018-22631-z","article-title":"IMPPAT: a curated database of Indian medicinal plants, phytochemistry and therapeutics","volume":"8","author":"Mohanraj","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128780_bb0475","first-page":"335","article-title":"Association of elevated sulfatides and sulfotransferase activities with human renal cell carcinoma","volume":"49","author":"Sakakibara","year":"1989","journal-title":"Cancer Res."},{"issue":"35","key":"10.1016\/j.ijbiomac.2023.128780_bb0480","doi-asserted-by":"crossref","first-page":"9482","DOI":"10.1523\/JNEUROSCI.2287-07.2007","article-title":"Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy","volume":"27","author":"Ramakrishnan","year":"2007","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128780_bb0485","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/ijms24010233","article-title":"Sulfatide deficiency, an early Alzheimer\u2019s lipidomic signature, causes brain ventricular enlargement in the absence of classical neuropathological hallmarks","volume":"24","author":"Palavicini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128780_bb0490","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13024-021-00488-7","article-title":"Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer\u2019s disease-like neuroinflammation and cognitive impairment","volume":"16","author":"Qiu","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.128780_bb0495","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/glycob\/cwi043","article-title":"Testis-specific sulfoglycolipid, seminolipid, is essential for germ cell function in spermatogenesis","volume":"15","author":"Zhang","year":"2005","journal-title":"Glycobiology"},{"issue":"24","key":"10.1016\/j.ijbiomac.2023.128780_bb0500","doi-asserted-by":"crossref","first-page":"9998","DOI":"10.1073\/pnas.1217775110","article-title":"Sulfatides are required for renal adaptation to chronic metabolic acidosis","volume":"110","author":"Stettner","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0505","first-page":"729","article-title":"Developing therapeutic approaches for metachromatic leukodystrophy","volume":"7","author":"Patil","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.128780_bb0510","doi-asserted-by":"crossref","first-page":"24579","DOI":"10.1038\/srep24579","article-title":"Cerebral spinal fluid levels of cytokines are elevated in patients with metachromatic leukodystrophy","author":"Thibert","year":"2016","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.128780_bb0515","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.4049\/jimmunol.181.11.8077","article-title":"Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells","volume":"181","author":"Jeon","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0520","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.aca.2016.12.002","article-title":"Quantification of plasma sulfatides by mass spectrometry: utility for metachromatic leukodystrophy","volume":"955","author":"Saville","year":"2017","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0525","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00731489","article-title":"Treatment of gaucher disease with an enzyme inhibitor","volume":"13","author":"Radin","year":"1996","journal-title":"Glycoconj. J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128780_bb0530","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1042\/ETLS20180058","article-title":"Substrate reduction therapy for inborn errors of metabolism","volume":"3","author":"Yue","year":"2019","journal-title":"Emerg. Top Life Sci."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb0535","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/B978-0-444-59565-2.00055-1","article-title":"Enzyme replacement therapy and substrate reduction therapy in lysosomal storage disorders with neurological expression","volume":"113","author":"Valayannopoulos","year":"2013","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128780_bb0540","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10897-017-0137-0","article-title":"Attitudes of individuals with Gaucher disease toward substrate reduction therapies","volume":"27","author":"Wagner","year":"2018","journal-title":"J. Genet. Couns."},{"issue":"15","key":"10.1016\/j.ijbiomac.2023.128780_bb0545","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s40265-014-0296-3","article-title":"Eliglustat: first global approval","volume":"74","author":"Poole","year":"2014","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128780_bb0550","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/0006-291X(85)90183-4","article-title":"Inhibition of rat brain galactocerebroside sulfotransferase by triazine aromatic dyes: interaction with the 3\u2032-phosphoadenosine 5\u2032-phosphosulfate binding site","volume":"129","author":"Zaruba","year":"1985","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.128780_bb0555","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1021\/acsomega.3c00156","article-title":"IMPPAT 2.0: an enhanced and expanded phytochemical atlas of Indian medicinal plants. ACS","volume":"8","author":"Vivek-Ananth","year":"2023","journal-title":"Omega"},{"issue":"D1, 11","key":"10.1016\/j.ijbiomac.2023.128780_bb0560","doi-asserted-by":"crossref","first-page":"D1317","DOI":"10.1093\/nar\/gkab941","article-title":"The natural products atlas 2.0: a database of microbially-derived natural products","volume":"50","author":"van Santen","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.ijbiomac.2023.128780_bb0565","doi-asserted-by":"crossref","first-page":"D611","DOI":"10.1093\/nar\/gkac868","article-title":"MiMeDB: the human microbial metabolome database","volume":"51","author":"Wishart","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128780_bb1015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/glia.10327","article-title":"Sulfatide is a negative regulator of oligodendrocyte differentiation: development in sulfatide-null mice","volume":"45","author":"Hirahara","year":"2004","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128780_bb1020","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1159\/000519005","article-title":"A Japanese patient with Gaucher disease treated with the oral drug eliglustat as substrate reducing therapy","volume":"15","author":"Komada","year":"2021","journal-title":"Case Rep. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb1025","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.807973","article-title":"Substrate reduction therapy for Krabbe disease: exploring the repurposing of the antibiotic D-cycloserine","volume":"9","author":"LeVine","year":"2022","journal-title":"Front. Pediatr."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128780_bb1030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1074\/jbc.M005666200","article-title":"Molecular cloning and characterization of a human beta-Gal-3\u2019-sulfotransferase that acts on both type 1 and type 2 (Gal beta 1-3\/1-4GlcNAc-R) oligosaccharides","volume":"276","author":"Honke","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"26","key":"10.1016\/j.ijbiomac.2023.128780_bb1035","doi-asserted-by":"crossref","first-page":"24388","DOI":"10.1074\/jbc.M103135200","article-title":"Molecular cloning and expression of a novel human beta-Gal-3-O-sulfotransferase that acts preferentially on N-acetyllactosamine in N- and O-glycans","volume":"276","author":"Suzuki","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"28","key":"10.1016\/j.ijbiomac.2023.128780_bb1040","doi-asserted-by":"crossref","first-page":"25697","DOI":"10.1074\/jbc.M101558200","article-title":"Molecular cloning and characterization of a novel human galactose 3-O-sulfotransferase that transfers sulfate to gal beta 1-->3galNAc residue in O-glycans","volume":"276","author":"Seko","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"32","key":"10.1016\/j.ijbiomac.2023.128780_bb1045","doi-asserted-by":"crossref","first-page":"9260","DOI":"10.1021\/bi700014q","article-title":"Cerebroside sulfotransferase forms homodimers in living cells","volume":"46","author":"Yaghootfam","year":"2007","journal-title":"Biochem"},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.128780_bb1050","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1128\/MCB.01093-09","article-title":"Expression of a testis-specific form of Gal3st1 (CST), a gene essential for spermatogenesis, is regulated by the CTCF paralogous gene BORIS","volume":"30","author":"Suzuki","year":"2010","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.128780_bb1055","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10719-012-9454-6","article-title":"Peroxisome proliferator-activated receptor \u03b1 mediates enhancement of gene expression of cerebroside sulfotransferase in several murine organs","volume":"30","author":"Nakajima","year":"2013","journal-title":"Glycoconj. J."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.128780_bb1060","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1046\/j.1432-1327.2000.01139.x","article-title":"cDNA cloning, genomic cloning, and tissue-specific regulation of mouse cerebroside sulfotransferase","volume":"267","author":"Hirahara","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ijbiomac.2023.128780_bb1065","unstructured":"Singh N., Singh A.K. In silico structural modeling and binding site analysis of Cerebroside Sulfotransferase (CST) \u2013 a therapeutic target for developing substrate reduction therapy for metachromatic leukodystrophy. Under communication."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128780_bb1070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/abbi.2001.2368","article-title":"Structure and function of sulfotransferases","volume":"390","author":"Negishi","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"issue":"20","key":"10.1016\/j.ijbiomac.2023.128780_bb1075","doi-asserted-by":"crossref","first-page":"17928","DOI":"10.1074\/jbc.M111651200","article-title":"Crystal structure of the human estrogen sulfotransferase-PAPS complex: evidence for catalytic role of Ser137 in the sulfuryl transfer reaction","volume":"277","author":"Pedersen","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.128780_bb1080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070880","article-title":"Insights into the N-sulfation mechanism: molecular dynamics simulations of the N-sulfotransferase domain of NDST1 and mutants","volume":"8","author":"Gesteira","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.128780_bb1085","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1073\/pnas.032068299","article-title":"Paranodal junction formation and spermatogenesis require sulfoglycolipids","volume":"99","author":"Honke","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128780_bb1090","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1074\/jbc.M305809200","article-title":"Cerebroside sulfotransferase deficiency ameliorates L-selectin-dependent monocyte infiltration in the kidney after ureteral obstruction","volume":"279","author":"Ogawa","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.ijbiomac.2023.128780_bb1095","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1002\/jnr.22003","article-title":"Adult CST-null mice maintain an increased number of oligodendrocytes","volume":"87","author":"Shroff","year":"2009","journal-title":"J. Neurosci. Res."},{"issue":"43","key":"10.1016\/j.ijbiomac.2023.128780_bb1100","doi-asserted-by":"crossref","first-page":"36283","DOI":"10.1074\/jbc.M112.403360","article-title":"A genetic model of substrate reduction therapy for mucopolysaccharidosis","volume":"287","author":"Lamanna","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128780_bb1105","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/oxfordjournals.jbchem.a021258","article-title":"Purification and characterization of 3\u2019-phosphoadenosine-5\u2019-phosphosulfate:GalCer sulfotransferase from human renal cancer cells","volume":"119","author":"Honke","year":"1996","journal-title":"J. Biochem."},{"issue":"1433","key":"10.1016\/j.ijbiomac.2023.128780_bb1110","first-page":"927","article-title":"Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disorders","volume":"358","author":"Butters","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.128780_bb1115","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1074\/jbc.272.8.4864","article-title":"Molecular cloning and expression of cDNA encoding human 3'- phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase","volume":"272","author":"Honke","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"Pt 1","key":"10.1016\/j.ijbiomac.2023.128780_bb1120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1042\/bj20020946","article-title":"N-glycosylation is required for full enzymic activity of the murine galactosylceramide sulphotransferase","volume":"368","author":"Eckhardt","year":"2002","journal-title":"Biochem. J."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023056799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023056799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T10:06:10Z","timestamp":1765793170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023056799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":134,"alternative-id":["S0141813023056799"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.128780","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive review on structural and therapeutical insight of Cerebroside sulfotransferase (CST) - An important target for development of substrate reduction therapy against metachromatic leukodystrophy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.128780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128780"}}